Caridad Pharmacy

17/02/2026

Kwaresma 2026
ASH WEDNESDAY MASS AND RITE SCHEDULE

16/02/2026

𝐄𝐍𝐑𝐈𝐊𝐀 𝐌𝐀𝐑𝐈𝐄 𝐂𝐀𝐃𝐈𝐙-𝐂𝐀𝐁𝐔𝐒𝐁𝐔𝐒𝐀𝐍
August 14, 1991 - February 11, 2026

Your immense service to the Department of Health Western Visayas Center for Health Development will forever be remembered and deeply treasured.

Thank you for the warmth, kindness, and the countless smiles you brought to everyone around you. Your presence made a difference in ways words can never fully express.

May your soul rest in eternal peace. 🤍

16/02/2026

13/02/2026

"I can buy myself flowers..."🎶🎶

13/02/2026

Let's Mung-GO to the Philippines this coming APLAR Midterm! Check out the APLAR-AYR IG page as well. (https://www.instagram.com/aplar_ayr/)

10/02/2026

Counseling Tip 👉 What to tell patients when dispensing antibiotics.

04/02/2026

04/02/2026

Ang autism indi kahinaan, kundi isa ka lain nga paagi sang pagtan-aw kag pagbatyag sang kalibutan. 💙

Sa Autism Consciousness Week, mangin bukas kita sa paghangop, pagbaton, kag paghatag suporta sa kada isa, labi na gid sa may autism.

Ulupdanay kita sa pag-pasanyog sang komunidad kung sa diin ang kada indibidwal nga may autism gina baton kag wala gina-descriminar.

Maging parte sang pag-palapnag kung ano ang Autism. Let’s take one step closer to an inclusive Philippines.

04/02/2026

𝗨𝗻𝗶𝘁𝗲𝗱 𝗯𝘆 𝗨𝗻𝗶𝗾𝘂𝗲: 𝗣𝗮𝗴-𝗮𝘀𝗮 𝗮𝘁 𝗣𝗮𝗴𝗸𝗮𝗸𝗮𝗶𝘀𝗮 𝗟𝗮𝗯𝗮𝗻 𝘀𝗮 𝗞𝗮𝗻𝘀𝗲𝗿

Ang buong buwan ng Pebrero ay ginugunita bilang National Cancer Awareness Month, kasabay ng World Cancer Day tuwing ika-4 ng Pebrero, isang pandaigdigang panawagan para sa pagkilos laban sa kanser.

Ang kanser ay nagaganap kapag may abnormal na pagdami ng cells sa katawan na maaaring makaapekto sa iba’t ibang bahagi at sistema nito. Ayon sa World Health Organization (WHO), malaking bahagi ng mga kaso ng kanser ay maaaring maiwasan o maagapan sa pamamagitan ng maagang screening, tamang kaalaman, at malusog na pamumuhay.

Ang pag-iwas sa bisyo tulad ng paninigarilyo at labis na pag-inom ng alak, pagkain ng masustansya, regular na ehersisyo, at pagkakaroon ng sapat na suporta mula sa pamilya at komunidad ay mahalagang bahagi ng laban kontra kanser.

Sa laban na ito, walang nag-iisa. Sa kaalaman, malasakit, at pagkakaisa, bawat buhay ay may pag-asa.

03/02/2026

Dahil February na ngayon, for a healthy pregnancy it is recommended that mothers do 8 minimum prenatal visits for better outcomes.

Kaya kapag wala sa capacity mag sagawa ng proper prenatal care, ayusin ang mga desisyon sa buhay.

16/01/2026

𝐅𝐃𝐀 𝐀𝐃𝐕𝐈𝐒𝐎𝐑𝐘 𝐒𝐓𝐀𝐓𝐄𝐌𝐄𝐍𝐓 𝐎𝐍 𝐑𝐄𝐏𝐎𝐑𝐓𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐑𝐄𝐂𝐀𝐋𝐋𝐄𝐃 𝐈𝐍𝐅𝐀𝐍𝐓 𝐅𝐎𝐑𝐌𝐔𝐋𝐀 𝐏𝐑𝐎𝐃𝐔𝐂𝐓𝐒

The Food and Drug Administration (FDA) advises the public on the status of reports received in relation to the ongoing voluntary recall of specific batches of NAN OPTIPRO and NANKID OPTIPRO infant formula products, as indicated in FDA Advisory 2026-0030.

As of 15 January 2026, the FDA has received twenty-five (25) reports associated with the recalled products. Eighteen (18) of these reports involve health concerns observed by parents or caregivers following consumption of the subject infant formula. Reported symptoms include vomiting, diarrhea, abdominal pain, and other conditions, some of which required medical attention.

All reports received by the FDA are subject to review to determine the appropriate regulatory actions. Each report is evaluated, and—when necessary—the FDA coordinates with relevant agencies and offices to ensure proper handling, verification, and resolution of the reported concerns.

The FDA continues to maintain close regulatory coordination with the Market Authorization Holder, Nestlé Philippines, Inc., which has been directed to submit regular and timely status reports on the implementation, assessment, and progress of the voluntary recall. Established procedures remain in place for the receipt, documentation, assessment, and appropriate disposition of consumer complaints, including reports of suspected adverse events. The FDA continues to exercise regulatory oversight of the recall through the review of information submitted by relevant parties and the conduct of post-market surveillance.

The FDA understands the concerns of parents and caregivers and encourages them to continue closely caring for and observing the well-being of their infants and young children. Should there be any concerns about a child’s health, seeking advice from a healthcare professional is encouraged. To help the FDA monitor the situation and provide appropriate assistance, parents and caregivers may also report any related concerns through ereport@fda.gov.ph.

The FDA remains committed to safeguarding public health, particularly the health and safety of infants and young children. Further information will be communicated as warranted, consistent with verified findings and established regulatory processes.